Literature DB >> 30188511

Interactive effects between hemizygous 15q13.3 microdeletion and peripubertal stress on adult behavioral functions.

Sandra Giovanoli1,2, Thomas M Werge3,4,5, Preben B Mortensen5,6,7, Michael Didriksen8, Urs Meyer9,10.   

Abstract

15q13.3 microdeletion is one of several gene copy number variants (CNVs) conferring increased risk of psychiatric and neurological disorders. This microdeletion gives rise to a variable spectrum of pathological phenotypes, ranging from asymptomatic to severe clinical outcomes. The reasons for these varying phenotypic outcomes remain unknown. Using a mouse model of hemizygous deletion of the orthologous region of 15q13.3, the present study examined whether exposure to stressful life events might interact with hemizygous 15q13.3 microdeletion in the development of behavioral dysfunctions. We show that hemizygous 15q13.3 microdeletion alone induces only limited effects on adult behaviors, but when combined with psychological stress in pubescence (postnatal days 30-40), it impairs sensorimotor gating and increases the sensitivity to the psychostimulant drug, amphetamine, at adult age. Stress exposure in adolescence (postnatal days 50-60) did not induce similar interactions with 15q13.3 microdeletion, but led to impaired emotional learning and memory and social behavior regardless of the genetic background. The present study provides the first evidence for interactive effects between hemizygous 15q13.3 microdeletion and exposure to stressful life events, and at the same time, it emphasizes an important influence of the precise timing of postnatal stress exposure in these interactions. Our findings suggest that hemizygous 15q13.3 microdeletion can act as a "disease primer" that increases the carrier's vulnerability to the detrimental effects of peripubertal stress exposure on adult behaviors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30188511      PMCID: PMC6372643          DOI: 10.1038/s41386-018-0189-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  50 in total

Review 1.  Negative symptoms of schizophrenia: a problem that will not go away.

Authors:  S M Stahl; P F Buckley
Journal:  Acta Psychiatr Scand       Date:  2007-01       Impact factor: 6.392

Review 2.  Measuring normal and pathological anxiety-like behaviour in mice: a review.

Authors:  C Belzung; G Griebel
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

Review 3.  The ascent of mouse: advances in modelling human depression and anxiety.

Authors:  John F Cryan; Andrew Holmes
Journal:  Nat Rev Drug Discov       Date:  2005-09       Impact factor: 84.694

Review 4.  Structural variation of the human genome.

Authors:  Andrew J Sharp; Ze Cheng; Evan E Eichler
Journal:  Annu Rev Genomics Hum Genet       Date:  2006       Impact factor: 8.929

Review 5.  The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies.

Authors:  M Laruelle
Journal:  Brain Res Brain Res Rev       Date:  2000-03

Review 6.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

7.  Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures.

Authors:  Davide Franceschini; Richard Paylor; Ron Broide; Ramiro Salas; Laura Bassetto; Cecilia Gotti; Mariella De Biasi
Journal:  Brain Res Mol Brain Res       Date:  2002-01-31

8.  Large-scale copy number polymorphism in the human genome.

Authors:  Jonathan Sebat; B Lakshmi; Jennifer Troge; Joan Alexander; Janet Young; Pär Lundin; Susanne Månér; Hillary Massa; Megan Walker; Maoyen Chi; Nicholas Navin; Robert Lucito; John Healy; James Hicks; Kenny Ye; Andrew Reiner; T Conrad Gilliam; Barbara Trask; Nick Patterson; Anders Zetterberg; Michael Wigler
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

9.  Failure of extinction of fear responses in posttraumatic stress disorder: evidence from second-order conditioning.

Authors:  Michèle Wessa; Herta Flor
Journal:  Am J Psychiatry       Date:  2007-11       Impact factor: 18.112

10.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

View more
  5 in total

Review 1.  Opportunities in precision psychiatry using PET neuroimaging in psychosis.

Authors:  Jennifer M Coughlin; Andrew G Horti; Martin G Pomper
Journal:  Neurobiol Dis       Date:  2019-03-20       Impact factor: 5.996

2.  Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development.

Authors:  Sharon K Hunter; M Camille Hoffman; Angelo D'Alessandro; Kathleen Noonan; Anna Wyrwa; Robert Freedman; Amanda J Law
Journal:  Psychol Med       Date:  2019-12-02       Impact factor: 7.723

3.  Time of exposure to social defeat stress during childhood and adolescence and redox dysregulation on long-lasting behavioral changes, a translational study.

Authors:  Mirko Schnider; Raoul Jenni; Julie Ramain; Sara Camporesi; Philippe Golay; Luis Alameda; Philippe Conus; Kim Q Do; Pascal Steullet
Journal:  Transl Psychiatry       Date:  2022-09-26       Impact factor: 7.989

4.  Separable neural mechanisms for the pleiotropic association of copy number variants with neuropsychiatric traits.

Authors:  Andreas Meyer-Lindenberg; Natalia Gass; Jonathan R Reinwald; Alexander Sartorius; Wolfgang Weber-Fahr; Markus Sack; Robert Becker; Michael Didriksen; Tine B Stensbøl; Adam J Schwarz
Journal:  Transl Psychiatry       Date:  2020-03-13       Impact factor: 6.222

5.  Neuronal activity increases translocator protein (TSPO) levels.

Authors:  Urs Meyer; Jeremy Hall; Tina Notter; Sina M Schalbetter; Nicholas E Clifton; Daniele Mattei; Juliet Richetto; Kerrie Thomas
Journal:  Mol Psychiatry       Date:  2020-05-12       Impact factor: 13.437

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.